Koenig Scott's Insider Trades & SAST Disclosures
Koenig Scott's most recent trade in Macrogenics Inc was a trade of 42,329 Common Stock done . Disclosure was reported to the exchange on Feb. 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Koenig Scott.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 15 Feb 2025 | 42,329 | 777,415 (1%) | 0% | 0 | Common Stock | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 15 Feb 2025 | 42,329 | 42,330 | - | - | Restricted Stock Unit | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 08 Feb 2025 | 31,673 | 735,086 (1%) | 0% | 0 | Common Stock | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 08 Feb 2025 | 31,673 | 63,327 | - | - | Restricted Stock Unit | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 07 Oct 2024 | 53,265 | 427,480 (0%) | 0% | - | Common Stock | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 07 Oct 2024 | 53,265 | 0 (0%) | 0% | - | Common Stock | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 23 Sep 2024 | 374,215 | 703,413 (1%) | 0% | - | Common Stock | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 23 Sep 2024 | 374,215 | 374,215 (0%) | 0% | - | Common Stock | ||
| GlycoMimetics Inc | Scott Koenig | Director | 01 May 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | ||
| Macrogenics Inc | Koenig Scott | Director, President and CEO | 15 Feb 2024 | 42,341 | 1,091,977 (2%) | 0% | 0 | Common Stock | ||
| Macrogenics Inc | Koenig Scott | Director, President and CEO | 15 Feb 2024 | 42,341 | 84,659 | - | - | Restricted Stock Unit | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 15 Feb 2024 | 14,349 | 1,077,628 (2%) | 0% | 17.4 | 249,673 | Common Stock | |
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 08 Feb 2024 | 248,000 | 248,000 | - | - | Employee Stock Option (right to buy) | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 08 Feb 2024 | 95,000 | 95,000 | - | - | Restricted Stock Unit | ||
| GlycoMimetics Inc | Scott Koenig | Director | 01 Jun 2023 | 21,000 | 0 | - | - | Stock option (right to buy) | ||
| GlycoMimetics Inc | Scott Koenig | Director | 01 Jun 2023 | 21,000 | 36,750 (0%) | 0% | 0.6 | 12,600 | Common Stock | |
| GlycoMimetics Inc | Scott Koenig | Director | 19 May 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 15 Feb 2023 | 510,000 | 510,000 | - | - | Employee stock option (right to buy) | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 15 Feb 2023 | 127,000 | 127,000 | - | - | Restricted Stock Unit | ||
| GlycoMimetics Inc | Scott Koenig | Director | 27 Jan 2023 | 10,500 | 0 | - | - | Stock Option (right to buy) | ||
| GlycoMimetics Inc | Scott Koenig | Director | 27 Jan 2023 | 10,500 | 15,750 (0%) | 0% | 2.6 | 26,775 | Common Stock | |
| GlycoMimetics Inc | Scott Koenig | Director | 18 May 2022 | 21,000 | 21,000 | - | - | Stock Option (right to buy) | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 16 May 2022 | 53,265 | 0 | - | - | Employee stock option (right to buy) | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 16 May 2022 | 53,265 | 1,049,636 (2%) | 0% | 1.5 | 80,430 | Common Stock | |
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 22 Feb 2022 | 480,000 | 480,000 | - | - | Employee stock option (right to buy) | ||
| GlycoMimetics Inc | Scott Koenig | Director | 18 May 2021 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | ||
| GlycoMimetics Inc | Scott Koenig | Director | 18 May 2021 | 5,250 | 5,250 (0%) | 0% | 0 | Common Stock | ||
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 22 Feb 2021 | 280,000 | 280,000 | - | - | Employee stock option (right to buy) | ||
| GlycoMimetics Inc | Scott Koenig | Director | 22 May 2020 | 21,000 | 21,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges